Earnings call transcript: Norsk Titanium Q2 2025 shows revenue growth, stock dips

Norsk Titanium reported a 54% year-over-year revenue increase to $2 million in Q2 2025, but its stock fell 7.86% as widening EBITDA losses of $15 million and a significant cash burn reduced holdings to $12 million. The company revised its 2026 revenue target to $70 million, pushed its $150 million target to 2028, and delayed cash flow breakeven to early 2027. To address liquidity, NTI plans a $15 million equity raise in Q3 2025, supported by major shareholders, as it navigates delayed aerospace transitions by diversifying its market focus.

Analysis

Norsk Titanium (NTI) reported contradictory Q2 2025 results, revealing a precarious financial position despite strong top-line growth. While revenue increased 54% year-over-year to $2 million, this was overshadowed by a widening EBITDA loss of $15 million and a severe depletion of cash reserves, which fell from $23 million to $12 million. The company's monthly cash burn of $2.9 million implies a runway of just over four months, making the planned $15 million equity raise in Q3 2025 critical for operational continuity. The stock's 7.86% decline and 81% drop over the past year reflect investor alarm over these metrics, which are further underscored by an InvestingPro financial health score of "WEAK" and a staggering gross profit margin of -4,198%. In response to persistent delays in aerospace part transitions, management has significantly revised its outlook, pushing its $150 million revenue ambition from 2026 to 2028 and delaying cash flow breakeven to early 2027. While the company holds a potential first-mover advantage as a unique supplier of additive titanium parts, its ability to monetize this position is unproven, forcing a strategic pivot toward diversifying its customer base into industrial and defense markets to mitigate its dependence on the challenging aerospace sector.

Key Decisions for Investors

• Given the company's monthly cash burn of $2.9 million against $12 million in cash, the successful completion of the planned $15 million equity raise in Q3 2025 is a critical short-term catalyst and must be monitored as a key determinant of the company's solvency.
• Investors should treat the revised $70 million revenue target for 2026 with caution, closely tracking contract announcements and revenue from new industrial and defense segments to validate management's turnaround and diversification strategy.
• The stock's valuation reflects significant distress, so any material progress on the delayed large-scale Airbus production order could serve as a powerful short-term catalyst, but the position remains highly speculative until revenue generation and cash flow stabilize.
• The extreme negative gross profit margin of -4,198% signals fundamental operational inefficiencies, and potential investors should await clear evidence of a path to positive unit economics before considering a long position.